Carcinoma Matrix Controls Resistance to Cisplatin through Talin Regulation of NF-kB

Open Access

Peer-reviewed

Research Article

Karen E. Eberle,

Affiliation Department of Oral and Craniofacial Biology, School of Dentistry, Louisiana State University Health Sciences Center-New Orleans, New Orleans, Louisiana, United States of America
⨯
Hope A. Sansing,

Affiliation Department of Oral and Craniofacial Biology, School of Dentistry, Louisiana State University Health Sciences Center-New Orleans, New Orleans, Louisiana, United States of America
⨯
Peter Szaniszlo,

Affiliation Department of Otolaryngology, University of Texas Medical Branch Cancer Center, University of Texas Medical Branch Health, Galveston, Texas, United States of America
⨯
Vicente A. Resto,

Affiliation Department of Otolaryngology, University of Texas Medical Branch Cancer Center, University of Texas Medical Branch Health, Galveston, Texas, United States of America
⨯
Allison L. Berrier

* E-mail: allison.berrier@gmail.com

Affiliation Department of Oral and Craniofacial Biology, School of Dentistry, Louisiana State University Health Sciences Center-New Orleans, New Orleans, Louisiana, United States of America
⨯

Reader Comments (0)

Carcinoma
Is the Subject Area "Carcinoma" applicable to this article?

Thanks for your feedback.
Integrins
Is the Subject Area "Integrins" applicable to this article?

Thanks for your feedback.
Collagens
Is the Subject Area "Collagens" applicable to this article?

Thanks for your feedback.
Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.
Luciferase
Is the Subject Area "Luciferase" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Hyperexpression techniques
Is the Subject Area "Hyperexpression techniques" applicable to this article?

Thanks for your feedback.